Concepedia

Cornelia Handl

CH

Statistics

Publications

3

Citations

46

H-Index

3

Active since

2021

Affiliations

Roche (Switzerland)(Current)

Cornelia Handl is an author at Roche (Switzerland) specializing in brain metastasis trials, braf v600 mutations, and mek inhibition.

ORCID

Publications per year

2021–2025

3

Publications

3

Preclinical Characterization of a Next-Generation Brain Permeable, Paradox Breaker BRAF Inhibitor

Jürgen Wichmann, Caroline Rynn, Thomas Friess et al. · Clinical Cancer Research · 2021 · 20 citations · Full text

, , +13

Targeting the SHOC2–RAS interaction in RAS-mutant cancers

Zachary J. Hauseman, Frédéric Stauffer, Kim S. Beyer et al. · Nature · 2025 · 16 citations · Full text

, , +15

Activity and Resistance of a Brain-Permeable Paradox Breaker BRAF Inhibitor in Melanoma Brain Metastasis

Ester Bonfill‐Teixidor, Raffaella Iurlaro, Cornelia Handl et al. · Cancer Research · 2022 · 10 citations · Full text

, , +17

1–3 of 3